カテゴリー： QYResearch, 世界

世界のヒレセプチンバイオシミラー市場 2019年

【英語タイトル】Global Hereceptin Biosimilar Market Professional Survey Report 2019

QYResearchが出版した調査資料（DATA909X08964）・商品コード：DATA909X08964
・発行会社（調査会社）：QYResearch
・発行日：2019年11月20日（※2024年版があります。お問い合わせください）
・ページ数：106
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後3営業日）
・調査対象地域：グローバル
・産業分野：医薬品・ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,500 ⇒換算￥518,000見積依頼/購入/質問フォーム
Multi User（5名様閲覧用）USD5,250 ⇒換算￥777,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD7,000 ⇒換算￥1,036,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・郵送（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
※本調査レポートは、ヒレセプチンバイオシミラーの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、タブレット、カプセルに、用途別には、医薬品、ヘルスケア、その他にセグメント区分し、ヒレセプチンバイオシミラーの世界市場を分析しました。


・エグゼクティブ・サマリー
・ヒレセプチンバイオシミラーの世界市場概要
・ヒレセプチンバイオシミラーの製造コスト構成分析
・ヒレセプチンバイオシミラーの開発・製造工場分析
・主要メーカーの主な指標（生産能力、売上、価格分析）
・ヒレセプチンバイオシミラーの地域別分析（生産、売上、主要メーカー、輸出・輸入）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・ヒレセプチンバイオシミラーのセグメント分析（種類別）
（タブレット、カプセル）
・ヒレセプチンバイオシミラーのセグメント分析（用途別）
（医薬品、ヘルスケア、その他）
・ヒレセプチンバイオシミラーの主要メーカー別分析（生産拠点、製品概要、生産・売上実績）
（Mylan N.V.、AryoGen Biopharma、Genor Biopharma、Celltrion Inc.、Amgen Inc.、Mabion S.A.、The Instituto Vital Brazil、F. Hoffmann-La Roche AG、Biocon、Gedeon Richter Plc、）
・ヒレセプチンバイオシミラーの市場規模予測（2019年～2025年）
（北米、ヨーロッパ、中国、日本国内、東南アジア、インド）
・マーケティングチャネル・流通業者・顧客
・市場ダイナミクス（市場動向、機会、成長要因、課題、影響因子）
...
【レポートの概要】

The global Hereceptin Biosimilar market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
This report focuses on Hereceptin Biosimilar volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hereceptin Biosimilar market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Hereceptin Biosimilar in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Hereceptin Biosimilar manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Mylan N.V.
AryoGen Biopharma
Genor Biopharma
Celltrion Inc.
Amgen Inc.
Mabion S.A.
The Instituto Vital Brazil
F. Hoffmann-La Roche AG
Biocon
Gedeon Richter Plc

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Tablet
Capsule

Segment by Application
Pharmaceuticals
Healthcare
Others

【レポートの目次】

Table of Contents

Executive Summary
1 Industry Overview of Hereceptin Biosimilar
1.1 Definition of Hereceptin Biosimilar
1.2 Hereceptin Biosimilar Segment by Type
1.2.1 Global Hereceptin Biosimilar Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Tablet
1.2.3 Capsule
1.3 Hereceptin Biosimilar Segment by Applications
1.3.1 Global Hereceptin Biosimilar Consumption Comparison by Applications (2014-2025)
1.3.2 Pharmaceuticals
1.3.3 Healthcare
1.3.4 Others
1.4 Global Hereceptin Biosimilar Overall Market
1.4.1 Global Hereceptin Biosimilar Revenue (2014-2025)
1.4.2 Global Hereceptin Biosimilar Production (2014-2025)
1.4.3 North America Hereceptin Biosimilar Status and Prospect (2014-2025)
1.4.4 Europe Hereceptin Biosimilar Status and Prospect (2014-2025)
1.4.5 China Hereceptin Biosimilar Status and Prospect (2014-2025)
1.4.6 Japan Hereceptin Biosimilar Status and Prospect (2014-2025)
1.4.7 Southeast Asia Hereceptin Biosimilar Status and Prospect (2014-2025)
1.4.8 India Hereceptin Biosimilar Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Hereceptin Biosimilar
2.3 Manufacturing Process Analysis of Hereceptin Biosimilar
2.4 Industry Chain Structure of Hereceptin Biosimilar

3 Development and Manufacturing Plants Analysis of Hereceptin Biosimilar
3.1 Capacity and Commercial Production Date
3.2 Global Hereceptin Biosimilar Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Hereceptin Biosimilar
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Hereceptin Biosimilar Production and Capacity Analysis
4.2 Hereceptin Biosimilar Revenue Analysis
4.3 Hereceptin Biosimilar Price Analysis
4.4 Market Concentration Degree

5 Hereceptin Biosimilar Regional Market Analysis
5.1 Hereceptin Biosimilar Production by Regions
5.1.1 Global Hereceptin Biosimilar Production by Regions
5.1.2 Global Hereceptin Biosimilar Revenue by Regions
5.2 Hereceptin Biosimilar Consumption by Regions
5.3 North America Hereceptin Biosimilar Market Analysis
5.3.1 North America Hereceptin Biosimilar Production
5.3.2 North America Hereceptin Biosimilar Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Hereceptin Biosimilar Import and Export
5.4 Europe Hereceptin Biosimilar Market Analysis
5.4.1 Europe Hereceptin Biosimilar Production
5.4.2 Europe Hereceptin Biosimilar Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Hereceptin Biosimilar Import and Export
5.5 China Hereceptin Biosimilar Market Analysis
5.5.1 China Hereceptin Biosimilar Production
5.5.2 China Hereceptin Biosimilar Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Hereceptin Biosimilar Import and Export
5.6 Japan Hereceptin Biosimilar Market Analysis
5.6.1 Japan Hereceptin Biosimilar Production
5.6.2 Japan Hereceptin Biosimilar Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Hereceptin Biosimilar Import and Export
5.7 Southeast Asia Hereceptin Biosimilar Market Analysis
5.7.1 Southeast Asia Hereceptin Biosimilar Production
5.7.2 Southeast Asia Hereceptin Biosimilar Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Hereceptin Biosimilar Import and Export
5.8 India Hereceptin Biosimilar Market Analysis
5.8.1 India Hereceptin Biosimilar Production
5.8.2 India Hereceptin Biosimilar Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Hereceptin Biosimilar Import and Export

6 Hereceptin Biosimilar Segment Market Analysis (by Type)
6.1 Global Hereceptin Biosimilar Production by Type
6.2 Global Hereceptin Biosimilar Revenue by Type
6.3 Hereceptin Biosimilar Price by Type

7 Hereceptin Biosimilar Segment Market Analysis (by Application)
7.1 Global Hereceptin Biosimilar Consumption by Application
7.2 Global Hereceptin Biosimilar Consumption Market Share by Application (2014-2019)

8 Hereceptin Biosimilar Major Manufacturers Analysis
8.1 Mylan N.V.
8.1.1 Mylan N.V. Hereceptin Biosimilar Production Sites and Area Served
8.1.2 Mylan N.V. Product Introduction, Application and Specification
8.1.3 Mylan N.V. Hereceptin Biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 AryoGen Biopharma
8.2.1 AryoGen Biopharma Hereceptin Biosimilar Production Sites and Area Served
8.2.2 AryoGen Biopharma Product Introduction, Application and Specification
8.2.3 AryoGen Biopharma Hereceptin Biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Genor Biopharma
8.3.1 Genor Biopharma Hereceptin Biosimilar Production Sites and Area Served
8.3.2 Genor Biopharma Product Introduction, Application and Specification
8.3.3 Genor Biopharma Hereceptin Biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Celltrion Inc.
8.4.1 Celltrion Inc. Hereceptin Biosimilar Production Sites and Area Served
8.4.2 Celltrion Inc. Product Introduction, Application and Specification
8.4.3 Celltrion Inc. Hereceptin Biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Amgen Inc.
8.5.1 Amgen Inc. Hereceptin Biosimilar Production Sites and Area Served
8.5.2 Amgen Inc. Product Introduction, Application and Specification
8.5.3 Amgen Inc. Hereceptin Biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Mabion S.A.
8.6.1 Mabion S.A. Hereceptin Biosimilar Production Sites and Area Served
8.6.2 Mabion S.A. Product Introduction, Application and Specification
8.6.3 Mabion S.A. Hereceptin Biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 The Instituto Vital Brazil
8.7.1 The Instituto Vital Brazil Hereceptin Biosimilar Production Sites and Area Served
8.7.2 The Instituto Vital Brazil Product Introduction, Application and Specification
8.7.3 The Instituto Vital Brazil Hereceptin Biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 F. Hoffmann-La Roche AG
8.8.1 F. Hoffmann-La Roche AG Hereceptin Biosimilar Production Sites and Area Served
8.8.2 F. Hoffmann-La Roche AG Product Introduction, Application and Specification
8.8.3 F. Hoffmann-La Roche AG Hereceptin Biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Biocon
8.9.1 Biocon Hereceptin Biosimilar Production Sites and Area Served
8.9.2 Biocon Product Introduction, Application and Specification
8.9.3 Biocon Hereceptin Biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 Gedeon Richter Plc
8.10.1 Gedeon Richter Plc Hereceptin Biosimilar Production Sites and Area Served
8.10.2 Gedeon Richter Plc Product Introduction, Application and Specification
8.10.3 Gedeon Richter Plc Hereceptin Biosimilar Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served

9 Development Trend of Analysis of Hereceptin Biosimilar Market
9.1 Global Hereceptin Biosimilar Market Trend Analysis
9.1.1 Global Hereceptin Biosimilar Market Size (Volume and Value) Forecast 2019-2025
9.2 Hereceptin Biosimilar Regional Market Trend
9.2.1 North America Hereceptin Biosimilar Forecast 2019-2025
9.2.2 Europe Hereceptin Biosimilar Forecast 2019-2025
9.2.3 China Hereceptin Biosimilar Forecast 2019-2025
9.2.4 Japan Hereceptin Biosimilar Forecast 2019-2025
9.2.5 Southeast Asia Hereceptin Biosimilar Forecast 2019-2025
9.2.6 India Hereceptin Biosimilar Forecast 2019-2025
9.3 Hereceptin Biosimilar Market Trend (Product Type)
9.4 Hereceptin Biosimilar Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Hereceptin Biosimilar Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

List of Tables and Figures
Figure Picture of Hereceptin Biosimilar
Table Global Hereceptin Biosimilar Production (MT) Growth Rate Comparison by Types (2014-2025)
Figure Global Hereceptin Biosimilar Production Market Share by Types in 2018
Figure Tablet Product Picture
Figure Capsule Product Picture
Table Global Hereceptin Biosimilar Consumption (MT) Comparison by Applications (2014-2025)
Figure Global Hereceptin Biosimilar Consumption Market Share by Applications in 2018
Figure Pharmaceuticals
Figure Healthcare
Figure Others
Figure Global Hereceptin Biosimilar Revenue (Million USD) (2014-2025)
Figure Global Hereceptin Biosimilar Production (MT) (2014-2025)
Figure North America Hereceptin Biosimilar Market Size (Million USD) (2014-2025)
Figure Europe Hereceptin Biosimilar Market Size (Million USD) (2014-2025)
Figure China Hereceptin Biosimilar Market Size (Million USD) (2014-2025)
Figure Japan Hereceptin Biosimilar Market Size (Million USD) (2014-2025)
Figure Southeast Asia Hereceptin Biosimilar Market Size (Million USD) (2014-2025)
Figure India Hereceptin Biosimilar Market Size (Million USD) (2014-2025)
Table Hereceptin Biosimilar Raw Material and Suppliers
Table Manufacturing Cost Structure Analysis of Hereceptin Biosimilar in 2018
Figure Manufacturing Process Analysis of Hereceptin Biosimilar
Figure Industry Chain Structure of Hereceptin Biosimilar
Table Capacity and Commercial Production Date of Key Manufacturers
Table Global Hereceptin Biosimilar Manufacturing Plants Distribution
Table Hereceptin Biosimilar Major Manufacturers Technology Source and Market Position
Table Recent Development and Expansion Plans in Future
Table Hereceptin Biosimilar Capacity (MT) of Major Manufacturers (2014-2019)
Table Hereceptin Biosimilar Production (MT) of Major Manufacturers (2014-2019)
Table Hereceptin Biosimilar Production Market Share of Major Manufacturers (2014-2019)
Figure Hereceptin Biosimilar Production Share by Manufacturers in 2018
Table Hereceptin Biosimilar Revenue (Million US$) of Major Manufacturers (2014-2019)
Table Hereceptin Biosimilar Revenue Market Share of Major Manufacturers (2014-2019)
Figure Hereceptin Biosimilar Revenue Share by Manufacturers in 2018
Table Hereceptin Biosimilar Average Price (K USD/Kg) of Major Manufacturers (2014-2019)
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Global Hereceptin Biosimilar Production by Regions 2014-2019 (MT)
Table Global Hereceptin Biosimilar Production Market Share by Regions 2014-2019
Figure Global Hereceptin Biosimilar Production Market Share by Regions in 2018
Table Global Hereceptin Biosimilar Revenue by Regions 2014-2019 (Million USD)
Table Global Hereceptin Biosimilar Revenue Market Share by Regions 2014-2019
Figure Global Hereceptin Biosimilar Revenue Market Share by Regions in 2018
Table Global Hereceptin Biosimilar Consumption by Regions 2014-2019 (MT)
Table Global Hereceptin Biosimilar Consumption Market Share by Regions 2014-2019
Figure North America Hereceptin Biosimilar Production Growth Rate 2014-2019 (MT)
Figure North America Hereceptin Biosimilar Revenue Growth Rate 2014-2019 (Million USD)
Table North America Hereceptin Biosimilar Production, Consumption Import and Export (MT)
Figure Europe Hereceptin Biosimilar Production Growth Rate 2014-2019 (MT)
Figure Europe Hereceptin Biosimilar Revenue Growth Rate 2014-2019 (Million USD)
Table Europe Hereceptin Biosimilar Production, Consumption Import and Export (MT)
Figure China Hereceptin Biosimilar Production Growth Rate 2014-2019 (MT)
Figure China Hereceptin Biosimilar Revenue Growth Rate 2014-2019 (Million USD)
Table China Hereceptin Biosimilar Production, Consumption Import and Export (MT)
Figure Japan Hereceptin Biosimilar Production Growth Rate 2014-2019 (MT)
Figure Japan Hereceptin Biosimilar Revenue Growth Rate 2014-2019 (Million USD)
Table Japan Hereceptin Biosimilar Production, Consumption Import and Export (MT)
Figure Southeast Asia Hereceptin Biosimilar Production Growth Rate 2014-2019 (MT)
Figure Southeast Asia Hereceptin Biosimilar Revenue Growth Rate 2014-2019 (Million USD)
Table Southeast Asia Hereceptin Biosimilar Production, Consumption Import and Export (MT)
Figure India Hereceptin Biosimilar Production Growth Rate 2014-2019 (MT)
Figure India Hereceptin Biosimilar Revenue Growth Rate 2014-2019 (Million USD)
Table India Hereceptin Biosimilar Production, Consumption Import and Export (MT)
Figure Global Consumption Hereceptin Biosimilar Market Share by Application (2014-2019)
Figure Global Value (Consumption) Hereceptin Biosimilar Market Share by Application (2014-2019)
Table Mylan N.V. Hereceptin Biosimilar Production Sites and Area Served
Table Mylan N.V. Hereceptin Biosimilar Product Introduction, Application and Specification
Table Mylan N.V. Hereceptin Biosimilar Production (MT), Revenue (Million USD), Ex-factory Price (K USD/Kg) and Gross Margin (2014-2019)
Table Mylan N.V. Hereceptin Biosimilar Production Growth Rate (2014-2019)
Table Mylan N.V. Hereceptin Biosimilar Production Market Share (2014-2019)
Figure Mylan N.V. Hereceptin Biosimilar Revenue Market Share (2014-2019)
Table Mylan N.V. Hereceptin Biosimilar Main Business and Markets Served
Table AryoGen Biopharma Hereceptin Biosimilar Production Sites and Area Served
Table AryoGen Biopharma Hereceptin Biosimilar Product Introduction, Application and Specification
Table AryoGen Biopharma Hereceptin Biosimilar Production (MT), Revenue (Million USD), Ex-factory Price (K USD/Kg) and Gross Margin (2014-2019)
Table AryoGen Biopharma Hereceptin Biosimilar Production Growth Rate (2014-2019)
Table AryoGen Biopharma Hereceptin Biosimilar Production Market Share (2014-2019)
Figure AryoGen Biopharma Hereceptin Biosimilar Revenue Market Share (2014-2019)
Table AryoGen Biopharma Hereceptin Biosimilar Main Business and Markets Served
Table Genor Biopharma Hereceptin Biosimilar Production Sites and Area Served
Table Genor Biopharma Hereceptin Biosimilar Product Introduction, Application and Specification
Table Genor Biopharma Hereceptin Biosimilar Production (MT), Revenue (Million USD), Ex-factory Price (K USD/Kg) and Gross Margin (2014-2019)
Table Genor Biopharma Hereceptin Biosimilar Production Growth Rate (2014-2019)
Table Genor Biopharma Hereceptin Biosimilar Production Market Share (2014-2019)
Figure Genor Biopharma Hereceptin Biosimilar Revenue Market Share (2014-2019)
Table Genor Biopharma Hereceptin Biosimilar Main Business and Markets Served
Table Celltrion Inc. Hereceptin Biosimilar Production Sites and Area Served
Table Celltrion Inc. Hereceptin Biosimilar Product Introduction, Application and Specification
Table Celltrion Inc. Hereceptin Biosimilar Production (MT), Revenue (Million USD), Ex-factory Price (K USD/Kg) and Gross Margin (2014-2019)
Table Celltrion Inc. Hereceptin Biosimilar Production Growth Rate (2014-2019)
Table Celltrion Inc. Hereceptin Biosimilar Production Market Share (2014-2019)
Figure Celltrion Inc. Hereceptin Biosimilar Revenue Market Share (2014-2019)
Table Celltrion Inc. Hereceptin Biosimilar Main Business and Markets Served
Table Amgen Inc. Hereceptin Biosimilar Production Sites and Area Served
Table Amgen Inc. Hereceptin Biosimilar Product Introduction, Application and Specification
Table Amgen Inc. Hereceptin Biosimilar Production (MT), Revenue (Million USD), Ex-factory Price (K USD/Kg) and Gross Margin (2014-2019)
Table Amgen Inc. Hereceptin Biosimilar Production Growth Rate (2014-2019)
Table Amgen Inc. Hereceptin Biosimilar Production Market Share (2014-2019)
Figure Amgen Inc. Hereceptin Biosimilar Revenue Market Share (2014-2019)
Table Amgen Inc. Hereceptin Biosimilar Main Business and Markets Served
Table Mabion S.A. Hereceptin Biosimilar Production Sites and Area Served
Table Mabion S.A. Hereceptin Biosimilar Product Introduction, Application and Specification
Table Mabion S.A. Hereceptin Biosimilar Production (MT), Revenue (Million USD), Ex-factory Price (K USD/Kg) and Gross Margin (2014-2019)
Table Mabion S.A. Hereceptin Biosimilar Production Growth Rate (2014-2019)
Table Mabion S.A. Hereceptin Biosimilar Production Market Share (2014-2019)
Figure Mabion S.A. Hereceptin Biosimilar Revenue Market Share (2014-2019)
Table Mabion S.A. Hereceptin Biosimilar Main Business and Markets Served
Table The Instituto Vital Brazil Hereceptin Biosimilar Production Sites and Area Served
Table The Instituto Vital Brazil Hereceptin Biosimilar Product Introduction, Application and Specification
Table The Instituto Vital Brazil Hereceptin Biosimilar Production (MT), Revenue (Million USD), Ex-factory Price (K USD/Kg) and Gross Margin (2014-2019)
Table The Instituto Vital Brazil Hereceptin Biosimilar Production Growth Rate (2014-2019)
Table The Instituto Vital Brazil Hereceptin Biosimilar Production Market Share (2014-2019)
Figure The Instituto Vital Brazil Hereceptin Biosimilar Revenue Market Share (2014-2019)
Table The Instituto Vital Brazil Hereceptin Biosimilar Main Business and Markets Served
Table F. Hoffmann-La Roche AG Hereceptin Biosimilar Production Sites and Area Served
Table F. Hoffmann-La Roche AG Hereceptin Biosimilar Product Introduction, Application and Specification
Table F. Hoffmann-La Roche AG Hereceptin Biosimilar Production (MT), Revenue (Million USD), Ex-factory Price (K USD/Kg) and Gross Margin (2014-2019)
Table F. Hoffmann-La Roche AG Hereceptin Biosimilar Production Growth Rate (2014-2019)
Table F. Hoffmann-La Roche AG Hereceptin Biosimilar Production Market Share (2014-2019)
Figure F. Hoffmann-La Roche AG Hereceptin Biosimilar Revenue Market Share (2014-2019)
Table F. Hoffmann-La Roche AG Hereceptin Biosimilar Main Business and Markets Served
Table Biocon Hereceptin Biosimilar Production Sites and Area Served
Table Biocon Hereceptin Biosimilar Product Introduction, Application and Specification
Table Biocon Hereceptin Biosimilar Production (MT), Revenue (Million USD), Ex-factory Price (K USD/Kg) and Gross Margin (2014-2019)
Table Biocon Hereceptin Biosimilar Production Growth Rate (2014-2019)
Table Biocon Hereceptin Biosimilar Production Market Share (2014-2019)
Figure Biocon Hereceptin Biosimilar Revenue Market Share (2014-2019)
Table Biocon Hereceptin Biosimilar Main Business and Markets Served
Table Gedeon Richter Plc Hereceptin Biosimilar Production Sites and Area Served
Table Gedeon Richter Plc Hereceptin Biosimilar Product Introduction, Application and Specification
Table Gedeon Richter Plc Hereceptin Biosimilar Production (MT), Revenue (Million USD), Ex-factory Price (K USD/Kg) and Gross Margin (2014-2019)
Table Gedeon Richter Plc Hereceptin Biosimilar Production Growth Rate (2014-2019)
Table Gedeon Richter Plc Hereceptin Biosimilar Production Market Share (2014-2019)
Figure Gedeon Richter Plc Hereceptin Biosimilar Revenue Market Share (2014-2019)
Table Gedeon Richter Plc Hereceptin Biosimilar Main Business and Markets Served
Figure Global Hereceptin Biosimilar Production (MT) Growth Rate Forecast 2019-2025
Figure Global Hereceptin Biosimilar Revenue (Million USD) Growth Rate Forecast 2019-2025
Figure Global Hereceptin Biosimilar Sales Price (K USD/Kg) Forecast 2019-2025
Figure North America Hereceptin Biosimilar Production Growth Rate Forecast 2019-2025 (MT)
Figure North America Hereceptin Biosimilar Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Europe Hereceptin Biosimilar Production Growth Rate Forecast 2019-2025 (MT)
Figure Europe Hereceptin Biosimilar Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure China Hereceptin Biosimilar Production Growth Rate Forecast 2019-2025 (MT)
Figure China Hereceptin Biosimilar Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Japan Hereceptin Biosimilar Production Growth Rate Forecast 2019-2025 (MT)
Figure Japan Hereceptin Biosimilar Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure Southeast Asia Hereceptin Biosimilar Production Growth Rate Forecast 2019-2025 (MT)
Figure Southeast Asia Hereceptin Biosimilar Revenue Growth Rate Forecast 2019-2025 (Million USD)
Figure India Hereceptin Biosimilar Production Growth Rate Forecast 2019-2025 (MT)
Figure India Hereceptin Biosimilar Revenue Growth Rate Forecast 2019-2025 (Million USD)
Table Global Production (MT) of Hereceptin Biosimilar by Type (2019-2025)
Table Global Consumption (MT) of Hereceptin Biosimilar by Application (2019-2025)
Table Hereceptin Biosimilar Distributors List
Table Hereceptin Biosimilar Customers List
Table Market Key Trends
Table Key Opportunities
Table Market Key Drivers
Table Key Challenges
Table Key Influence Factors
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


【掲載企業】

Mylan N.V.、AryoGen Biopharma、Genor Biopharma、Celltrion Inc.、Amgen Inc.、Mabion S.A.、The Instituto Vital Brazil、F. Hoffmann-La Roche AG、Biocon、Gedeon Richter Plc、

★調査レポート[世界のヒレセプチンバイオシミラー市場 2019年] (コード：DATA909X08964)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界のヒレセプチンバイオシミラー市場 2019年]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の神経バイオシミラー生物製剤市場 2019年
    DATA909X11937 / QYResearch / 2019年11月20日 / ※本調査レポートは、神経バイオシミラー生物製剤の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、神経導管、神経ラップ、神経移植、その他に、用途別には、直接神経修復/神経移植、神経移植にセグメント区分し、神経バイオシミラー生物製剤の世界市場を分析しました。 ・エグゼクティブ・サマリー ・神経バイオシミラー生物製剤の世界市場概要 ・神経バイオシミラー生物製剤の製造コスト構成分析 ・神経バイオシミラー生物製剤の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・神経バイオシミラー生物製剤の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・神経バイオシミラー生物製剤のセグメント分析（種類別） （神経導管、神経ラップ、神経移植、その他）...The global Nerve Biosimilar Biological Products market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Nerve Biosimilar Biological Products volume and value at global level, regional level and company level. From a global perspective, this report represents overall Nerve Biosimilar Biological Products market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Nerve Biosimilar Biological Products in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer...
  • 世界のインターフェロンアルファ-2bバイオシミラー市場 2019年
    DATA909X09983 / QYResearch / 2019年11月20日 / ※本調査レポートは、インターフェロンアルファ-2bバイオシミラーの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、長持ちタイプ、普通タイプに、用途別には、C型肝炎、B型肝炎、その他にセグメント区分し、インターフェロンアルファ-2bバイオシミラーの世界市場を分析しました。 ・エグゼクティブ・サマリー ・インターフェロンアルファ-2bバイオシミラーの世界市場概要 ・インターフェロンアルファ-2bバイオシミラーの製造コスト構成分析 ・インターフェロンアルファ-2bバイオシミラーの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・インターフェロンアルファ-2bバイオシミラーの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・インターフェロンアルファ-2bバイオシミラーのセグメント分析（種類別） （長持ちタイプ、普通タイプ）...The global Interferon Alpha-2b Biosimilar market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Interferon Alpha-2b Biosimilar volume and value at global level, regional level and company level. From a global perspective, this report represents overall Interferon Alpha-2b Biosimilar market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Interferon Alpha-2b Biosimilar in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes...
  • 世界のアダリムマブバイオシミラー市場 2019年
    DATA909X02951 / QYResearch / 2019年11月15日 / ※本調査レポートは、アダリムマブバイオシミラーの世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、タブレット、経口液に、用途別には、病院薬局、小売薬局、オンライン薬局にセグメント区分し、アダリムマブバイオシミラーの世界市場を分析しました。 ・エグゼクティブ・サマリー ・アダリムマブバイオシミラーの世界市場概要 ・アダリムマブバイオシミラーの製造コスト構成分析 ・アダリムマブバイオシミラーの開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・アダリムマブバイオシミラーの地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・アダリムマブバイオシミラーのセグメント分析（種類別） （タブレット、経口液）...The global Adalimumab Biosimilar market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Adalimumab Biosimilar volume and value at global level, regional level and company level. From a global perspective, this report represents overall Adalimumab Biosimilar market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Adalimumab Biosimilar in North America, Europe, China, Japan, Southeast Asia and India. For each manufacturer covered, this report analyzes their Adalimumab Biosimilar manufacturing...
  • 世界の多関節若年性特発性関節炎治療薬市場 2019年
    DATA909X13266 / QYResearch / 2019年11月20日 / ※本調査レポートは、多関節若年性特発性関節炎治療薬の世界市場概要、製造コスト分析、開発・製造工場分析、主要メーカー分析、地域別分析情報、市場規模予測データ、マーケティングチャネル、流通業者リスト、顧客リストなどが含まれています。種類別には、エタネルセプトバイオシミラー、トシリズマブバイオシミラー、サリルマブ、アダリムマブバイオシミラー、その他に、用途別には、病院、診療所、その他にセグメント区分し、多関節若年性特発性関節炎治療薬の世界市場を分析しました。 ・エグゼクティブ・サマリー ・多関節若年性特発性関節炎治療薬の世界市場概要 ・多関節若年性特発性関節炎治療薬の製造コスト構成分析 ・多関節若年性特発性関節炎治療薬の開発・製造工場分析 ・主要メーカーの主な指標（生産能力、売上、価格分析） ・多関節若年性特発性関節炎治療薬の地域別分析（生産、売上、主要メーカー、輸出・輸入） （北米、ヨーロッパ、中国、日本国内、東南アジア、インド） ・多関節若年性特発性関節炎治療薬のセグメント分析（種類別） （エタネルセプトバイオシミラー、トシリズマブバイオシミラー、サリルマブ、アダリムマブバイオシミラー、その他）...The global Polyarticular Juvenile Idiopathic Arthritis Drug market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025. This report focuses on Polyarticular Juvenile Idiopathic Arthritis Drug volume and value at global level, regional level and company level. From a global perspective, this report represents overall Polyarticular Juvenile Idiopathic Arthritis Drug market size by analyzing historical data and future prospect. Regionally, this report categorizes the production, apparent consumption, export and import of Polyarticular Juvenile Idiopathic Arthritis Drug in North America, Europe, China, Japan, Southeast Asia and...

    • ◆H&Iグローバルリサーチのお客様（例）◆